• Return to Headlines

Insys Therapeuti Down 34.4% Since SmarTrend Downtrend Call (INSY)

By Nick Russo

SmarTrend identified a Downtrend for Insys Therapeuti (NASDAQ:INSY) on October 23rd, 2018 at $7.85. In approximately 1 month, Insys Therapeuti has returned 34.35% as of today's recent price of $5.15.

In the past 52 weeks, shares of Insys Therapeuti have traded between a low of $4.10 and a high of $19.96 and are now at $5.15, which is 26% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 0.4% while the 50-day MA has declined 2.6%.

Insys Therapeutics, Inc. develops cancer support drugs. The Company support care candidates include a fast-acting sublingual spray for cancer pain and a dronabinol product used to treat chemotherapy-induced nausea and vomiting and to stimulate appetite in AIDS patients.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Insys Therapeuti.

Log in and add Insys Therapeuti (INSY) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights insys therapeuti

Ticker(s): INSY